iBreathe
com.feellife.iBreathe
Screenshots
Description
FEELLIFE is committed to providing a third way of dosing for humans, and innovating the "AiMesh" micro-mesh technology,
The digital cloud technology, creating a one-stop respiratory management APP, is designed to provide medical level management solutions for health and sub-health users who pay attention to their own respiratory health management.
Create medical equipment with advanced technology, portable intelligence, health and safety by ingenious technology, and bring benefits to human health. The company's products are exported to more than 50 countries and regions at home and abroad, and are deeply trusted and loved by global consumers.
The first nebulizer company in the world to use animation IP: in 2017, it cooperated with Font Animation to build a series of children's nebulizers in Bear Paradise! FEELLIFE makes aerosol treatment and health monitoring interesting!
The test data on "FeelLife" can only be used as test suggestions for users' reference. It is not used as a basis for diagnosis and treatment, nor as any legally effective written proof document, nor can it replace the doctor's interview and hospital diagnosis. If the user uses this as the basis for diagnosis and treatment, the questioner shall be responsible for any negative effects or even losses that may arise therefrom, and the "FeelLife" platform will not be responsible.
AppWisp - mobile app insights
AppWisp is a platform for mobile app insights. We provide a comprehensive overview of the mobile app ecosystem, including app store data, SDK usage, and more.
Free app store data
We provide free data on app store rankings, downloads and technology. Our data is updated daily and is available for both iOS and Android apps.
SDK insights
We provide insights into the SDKs used by mobile apps. Our data includes information on SDK usage, market share, and more.
API access
We offer an API that allows you to access our data programmatically. Our API is easy to use and provides access to all of our data.